- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02088437
High Intensity Physiotherapy for Hip Fractures (HIP4hips)
High Intensity Physiotherapy for Hip Fractures in the Acute Hospital Setting
Every day, more than 40 Australian break their hip, Most are over the age of sixty five. Hip fractures are a significant problem for the older people, the hospital system and community as a whole because of the increasing numbers of fractures and the cost of hospitalisation and ongoing care. After one year, less than half of all people with a hip fracture can walk as well as they did before the fracture. Physiotherapy in the acute hospital setting is an integral part of patient care, although the intensity of physiotherapy a patient receives is variable and the optimal number of treatment sessions per day remains unknown. Studies in other patient groups have shown that increased physiotherapy can improve patient outcomes by increasing muscle strength and mobility. It can also reduce the negative effects of bed rest such as muscle wasting, blood clots in the lungs or leg veins and chest infections such as pneumonia. This study aims to investigate the effectiveness of an intensive physiotherapy program in hip fracture patients to further understand this and the effect it has on patient function.
In this research the investigators will randomly allocate patients into 2 groups; usual care and intensive physiotherapy. The usual care group will have physiotherapy treatment daily whereas the intensive physiotherapy group will have an additional daily treatment by a physiotherapist as well as a daily treatment by an allied health assistant. The objectives are to achieve better functional outcomes in the patient's hospital stay (ie improved mobility), reduce the time for patients to be physically ready to go home, increase the number of patients able to go directly home or to fast stream rehabilitation (rather than a slow stream option).
If increased intensity of physiotherapy is found to improve patient's mobility outcomes, this research will provide the confidence to endorse a change to current clinical practice.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Victoria
-
Melbourne, Victoria, Austrália, 3181
- The Alfred
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Admission to The Alfred with an isolated hip fracture and treated with internal fixation, aged 65 or above
Exclusion Criteria:
- fracture is in the sub-trochanteric region of the femur,
- if it is pathological,
- if post operative orders are for non-weight bearing on the operated hip,
- if they were unable to mobilise independently (or with gait aid) prior to admission,
- or if they were admitted from a nursing home.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Usual care
usual care physiotherapy - once daily treatment whilst inpatient in acute hospital
|
once daily physiotherapy whilst acute hospital inpatient
|
|
Experimental: Intensive physiotherapy
additional once daily physiotherapy and once daily allied health assistant intervention
|
additional once daily physiotherapy and once daily allied health assistant intervention (equals two more treatments) whilst an inpatient in acute hospital
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
modified IOWA Level of Assistance Scale
Prazo: 5 days
|
Functional score measuring 6 mobility domains
|
5 days
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
length of stay - acute and rehabilitation
Prazo: participants will be followed for duration of hospital stay - average one month
|
the length of acute hospital stay and rehabilitation stay - until discharge home or to a long term facility
|
participants will be followed for duration of hospital stay - average one month
|
|
timed up and go
Prazo: 5 days
|
5 days
|
|
|
Glasgow Outcomes Score -Extended
Prazo: 6 months
|
6 months
|
|
|
discharge destination
Prazo: participants will be followed until discharge from the acute hospital - average 10 days
|
discharge destination from the acute hospital - options include: home, fast stream rehabilitation, slow stream rehabilitation, long term facility
|
participants will be followed until discharge from the acute hospital - average 10 days
|
|
physical readiness for discharge
Prazo: average one month
|
when a patient is deemed physically ready go home - eg can access their house and mobilise within house and outdoors
|
average one month
|
|
12-Item Short Form Health Survey (SF-12)
Prazo: 6 months
|
6 months
|
|
|
EuroQOL five dimensions questionnaire (EQ-5D)
Prazo: 6 months
|
6 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Lara A Kimmel, B.Physio, The Alfred
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 32/14
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .